Lrrk2 R1441 substitution and progressive supranuclear palsy
- 4 January 2006
- journal article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 32 (1) , 23-25
- https://doi.org/10.1111/j.1365-2990.2006.00693.x
Abstract
Mutation of the LRRK2 gene has been associated with autosomal dominant parkinsonism. An R1441C pathogenic substitution was identified in Family D, a large Western Nebraskan kindred, with four members demonstrating pleomorphic pathology at autopsy. One member of this family displayed tau pathology suggestive of progressive supranuclear palsy (PSP). To evaluate the influence of mutation at the R1441 residue in this disorder we screened a series of 242 pathologically confirmed PSP cases. No evidence was found for the presence of a mutation at this codon in our series. These data would suggest that this Lrrk2 variant does not contribute in susceptibility to PSP.Keywords
This publication has 19 references indexed in Scilit:
- Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European PopulationsAmerican Journal of Human Genetics, 2005
- A frequent gene mutation associated with autosomal dominant Parkinson's diseaseThe Lancet, 2005
- Genetic screening for a single common LRRK2 mutation in familial Parkinson's diseaseThe Lancet, 2005
- Multiple regions contribute to membrane targeting of Rab GTPasesJournal of Cell Science, 2004
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic PathologyNeuron, 2004
- Linkage Disequilibrium and Association of MAPT H1 in Parkinson DiseaseAmerican Journal of Human Genetics, 2004
- Novel haplotypes in 17q21 are associated with progressive supranuclear palsyAnnals of Neurology, 2004
- Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain BankMovement Disorders, 2003
- Genetic evidence for the involvement of τ in progressive supranuclear palsyAnnals of Neurology, 1997